Exploiting type 3 complement receptor for TNF-α suppression, immune evasion, and progressive pulmonary fungal infection

Journal of Immunology

Volumn 173, Issue 12, 2004, Pages 7444-7453

  Brandhorst, T Tristan ^a   Wüthrich, Marcel ^a   Finkel Jimenez, Bea ^a   Warner, Thomas ^a   Klein, Bruce S ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BLASTOMYCES ADHESIN 1 PROTEIN; CD14 ANTIGEN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR TYPE 3; CYTOCHALASIN D; DANSYLCADAVERINE; FC RECEPTOR; FUNGAL PROTEIN; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; APOPTOSIS; ARTICLE; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; CELL ADHESION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; ENDOSOME; HOST CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNE EVASION; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LUNG ALVEOLUS MACROPHAGE; LUNG HOMOGENATE; LUNG INFECTION; MALE; MOUSE; MYCOSIS; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; RECEPTOR BINDING;

EID: 10344263399     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.12.7444     Document Type: Article

References (55)

1. Harvey, R. P., E. S. Schmid, C. C. Carrington, and D. A. Stevens. 1978. Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters. Am. Rev. Respir. Dis. 117:695.
2. Wüthrich, M., W. L. Chang, and B. S. Klein. 1998. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect. Immun. 66:5443.
3. Brandhorst, T. T., M. Wüthrich, T. Warner, and B. S. Klein. 1999. Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J. Exp. Med. 189:1207.
4. Newman, S. L., S. Chaturvedi, and B. S. Klein. 1995. The WI-1 antigen on Blastomyces dermatitidis yeasts mediates binding to human macrophage CD18 and CD14 receptors. J. Immunol. 154:753.
5. Finkel-Jimenez, B., M. Wüthrich, T. T. Brandhorst, and B. S. Klein. 2001. Down-regulation of phagocyte TNF-α production by the WI-1 adhesin imparts pathogenicity on Blastomyces dermatitidis. J. Immunol. 166:2665.
6. Brandhorst, T. T., M. Wüthrich, B. Finkel-Jimenez, and B. S. Klein. 2003. A C-terminal EGF domain governs BAD1 localization to the yeast surface and fungal adherence to phagocytes, but is dispensable in immune modulation and pathogenicity of Blastomyces dermatitidis. Mol. Microbiol. 48:53.
7. Finkel-Jimenez, B., M. Wüthrich, and B. S. Klein. 2002. BAD1, an essential virulence factor of Blastomyces dermatitidis suppresses host TNF-α production through TGF-β dependent mechanisms. J. Immunol. 168:5746.
8. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987.
9. Sutterwala, F. S., and D. M. Mosser. 1999. The taming of IL-12: suppressing the production of proinflammatory cytokines. J. Leukocyte. Biol. 1999. 65:543.
10. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515.
11. Mosser, D. M., T. A. Springer, and M. S. Diamond. 1992. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-I (CD11b/CD18). J. Cell Biol. 116:511.
12. Zhang, Z., H. Correa, and R. E. Begue. 2002. Tuberculosis and treatment with infliximab. N. Engl. J. Med. 346:623.
13. Nakelchik, M., and J. E. Mangino. 2002. Reactivation of histoplasmosis after treatment with infliximab. Am. J. Med. 112:78.
14. McDermott, M. F. 2001. TNF and TNFR biology in health and disease. Cell. Mol. Biol. 47:619.
15. Allendoerfer, R., and G. S. Deepe, Jr. 1998. Blockade of endogenous TNF-α exacerbates primary and secondary pulmonary histoplasmosis by differential mechanisms. J. Immunol. 160:6072.
16. Klein, B. S., and J. M. Jones. 1994. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen. Infect. Immun. 62:3890.
17. Wüthrich, M., and B. S. Klein. 2000. Investigation of anti-WI-1 adhesin antibody mediated protection in experimental pulmonary blastomycosis. J. Infect. Dis. 181:1720.
18. Audet, R., T. T. Brandhorst, and B. S. Klein. 1997. Purification in quantity of the secreted form WI-1: a major adhesin on Blastomyces dermatitidis yeast. Protein Expression Purif. 11:219.
19. Vabulas, R. M., P. Ahmad-Nejad, C. da Costa, T. Miethke, C. J. Kirschning, H. Hacker, and H. Wagner. 2001. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor-signaling pathway in innate immune cells. J. Biol. Chem. 276:31332.
20. Van Leuven, F., J. J. Cassiman, and H. Van Den Berghe. 1980. Primary amines inhibit recycling of α2M receptors in fibroblasts. Cell 20:37.
21. Newman, S. L., C. Bucher, J. Rhodes, and W. E. Bullock. 1990. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages: cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest. 85:223.
22. Mukherjee, J., L. S. Zuckier, M. D. Scharff, and A. Casadevall. 1994. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38:580.
23. Mukherjee, J., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63:573.
24. Wüthrich, M., H. I. Filutowicz, T. Warner, and B. S. Klein. 2002. Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts. J. Immunol. 169:6969.
25. + T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197:1405.
26. Johnson, M. R., K. Wang, J. B. Smith, M. J. Heslin, and R. B. Diasio. 2000. Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. Anal. Biochem. 278:175.
27. Fisher, L. D., and G. van Belle. 1993. Biostatistics: A Methodology for the Health Sciences. Wiley, New York, p. 611.
28. Gibbons, J. D., and S. Chakraborti. 1992. Nonparametric Statistical Inference, 3rd Ed. Marcel Dekker, New York.
29. Klein, B. S., S. Chaturvedi, L. H. Hogan, J. M. Jones, and S. L. Newman. 1994. Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages. Infect. Immun. 62:3536.
30. Oksvold, M. P., E. Skarpen, L. Wierod, R. E. Paulsen, and H. S. Huitfeldt. 2001. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF. Eur. J. Cell Biol. 80:285.
31. Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Biol. 12:575.
32. Wüthrich, M., H. I. Fillutowicz, and B. S. Klein. 2000. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance. J. Clin. Invest. 106:1381.
33. Morelli, A. E., A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo, Jr., and A. W. Thomson. 2003. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101:611.
34. Chow, J. C., D. W. Young, D. T. Golenbock, W. J. Christ, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:10689.
35. Golenbock, D. T., and M. J. Fenton. 2001. Extolling the diversity of bacterial endotoxins. Nat. Immunol. 2:286.
36. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.
37. Poltorak, A., X. He, I. Smirnova, M.-Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.
38. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615.
39. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115.
40. Casadevall, A. 1995. Antibody mediated immunity and invasive fungal infections. Infect. Immun. 63:4211.
41. Taborda, C. P., J. Rivera, O. Zaragoza, and A. Casadevall. 2003. More is not necessarily better: prozone-like effects in passive immunization with IgG. J. Immunol. 170:3621.
42. Mosser, D. M., and P. J. Edelson. 1987. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature 327:329.
43. Wright, S. D., and S. C. Silverstein. 1983. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 158:2016.
44. Mosser, D. M., P. J. Edelson. 1985. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J. Immunol. 135:2785.
45. Moore, K. J., L. P. Andersson, R. R. Ingalls, B. G. Monks, R. Li, M. A. Arnaout, D. T. Golenbock, and M. W. Freeman. 2000. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 165:4272.
46. Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11.
47. Springer, T. A. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.
48. Anderson, D. C., T. K. Kishimoto, and C. W. Smith. 1995. Leukocyte adhesion deficiency and other disorders of leukocyte adherence and motility. In The Metabolic and Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, eds. McGraw-Hill, New York, p. 3955
49. Prince, J. E., C. F. Brayton, M. C. Fossett, J. A. Durand, S. L. Kaplan, C. W. Smith, and C. M. Ballantyne. 2001. The differential roles of LFA-1 and Mac-I in host defense against systemic infection with Streptococcus pneumoniae. J. Immunol. 166:7362.
50. 2 integrins in kinetics of bacteremia, extravasation, and tick acquisition of Anaplasma phagocytophila in mice. Blood 101:3257.
51. Rosen, H., S. Gordon, and R. J. North. 1989. Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells: absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells. J. Exp. Med. 170:27.
52. Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804.
53. Hellwig, S. M., H. F. van Oirschot, W. L. Hazenbos, A. B. van Spriel, F. R. Mooi, and J. G. van De Winkel. 2001. Targeting to Fcγ receptors, but not CR3 (CD11b/CD18), increases clearance of Bordetella pertussis. J. Infect. Dis. 183:871.
54. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143.
55. Romani, L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1.